An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

PYLARIFY TruVu™ (piflufolastat F 18) injection (also known as 18F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and ...

Recognising these subtle body changes can lead to an earlier diagnosis, when treatment is more likely to be successful ...

Artificial intelligence has bounded into the mainstream, into personal lives, classroom assignments and work meetings — so it should be no surprise to find it in doctors’ offices and emergency ...

Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...

Cost: New longevity portfolio includes core MRI for $999, $899 intro offer (about 30 minutes); core MRI plus head and neck for $1,799, $1,599 intro offer (45 minutes); and core MRI plus head, neck and ...

CLEVELAND — The FDA has reversed course and announced it will now review Moderna's mRNA flu vaccine application after initially declining to accept it earlier this month. The agency had raised ...

Whole-pelvis RT linked to improved PFS for patients with prostate cancer staged TrN0M0, while ADT linked to improved PFS in patients staged N1/M1 ...

A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...

When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery Wendy Grossman Kantor is an award-winning journalist who has contributed to PEOPLE ...

Prostate cancer burden in 2026 is high, with disproportionate incidence and mortality in Black men and major survival decrements in distant-stage disease, supporting equitable, stage-shifting ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...